A survey of Belgian clinical research professionals offers insights into the future of social media
The importance of focusing on both outcomes as early as possible in the product development cycle.
There has been a recent thrust within the pharmaceutical industry to promote the transformation of the clinical trial process.
Changes in biopharmaceutical R&D strategies and Technological innovations in clinical research are challenging payers on evaluating novel therapeutics and their involvement in the R&D process.
The catalog of theranostic markers (TMs), which consists of biomarkers that help to identify patient populations best poised to respond favorably to a specific therapy, continues to expand.
A recent survey conducted by Applied Clinical Trials and SCORR Marketing on mHealth in Clinical Trials.
As part of a global 4,000 site mail and on-line survey, we examined the reasons behind Latin American clinical investigators decision to take part in clinical research.
Study finds that almost 75% of cancer drug candidates rely on biomarker data.
This latest, updated eBook on Risk-Based Monitoring from Applied Clinical Trials includes the latest information on the topic being discussed around clinical trials. Includes pitfalls to avoid when implementing an RBM strategy, and an update on Cancer Research UK's implementation.
Every trial starts with a budget, and a clinical trial study start-up process that can be fraught with delays. From contract negotiations, to managing a trial for a sponsor, to streamlining study start-up process, this eBook seeks to instruct others on best practices.
With a growing need for post-marketing safety databases, and increased need to collect qualitative information from patients in the pre- and post-market of a drug the evidence gathering from clinical trials onward is expanding.